AZ Dyrk1B 33

Pricing Availability   Qty
说明: Potent and selective Dyrk1B kinase inhibitor
化学名: 3-(2-Methyl-4-pyrimidinyl)-1-(phenylmethyl)-1H-pyrrolo[2,3-c]pyridine
纯度: ≥98% (HPLC)
说明书
引用文献
评论
文献 (2)

生物活性 for AZ Dyrk1B 33

AZ Dyrk1B 33 is a potent and selective ATP-competitive Dyrk1B kinase inhibitor (IC50 = 7 nM); displays distinct cellular effects when compared to DYRK1B knockdown through siRNA. Demonstrates cellular in vitro activity (IC50 = 194 nM). Exhibits better selectivity than AZ 191 (Cat. No 5232); displays no off-target effects against a panel of 124 kinases tested (no kinase was inhibited above 50% at 1 μM).

化合物库 for AZ Dyrk1B 33

AZ Dyrk1B 33 is also offered as part of the Tocriscreen 2.0 Max and Tocriscreen Kinase Inhibitor Library. 了解 Tocris 化合物库的更多信息。

技术数据 for AZ Dyrk1B 33

分子量 300.36
公式 C19H16N4
储存 Store at +4°C
纯度 ≥98% (HPLC)
CAS Number 1679330-37-0
PubChem ID 118735338
InChI Key CZCUSHJQJWKYTD-UHFFFAOYSA-N
Smiles CC1=NC=CC(C2=CN(CC3=CC=CC=C3)C4=CN=CC=C42)=N1

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

溶解性数据 for AZ Dyrk1B 33

溶剂 最高浓度 mg/mL 最高浓度 mM
溶解性
1eq. HCl 30.04 100
DMSO 30.04 100

制备储备液 for AZ Dyrk1B 33

以下数据基于产品分子量 300.36。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

选择批次从而根据批次分子量重新计算:
浓度/溶剂体积/质量 1 mg 5 mg 10 mg
1 mM 3.33 mL 16.65 mL 33.29 mL
5 mM 0.67 mL 3.33 mL 6.66 mL
10 mM 0.33 mL 1.66 mL 3.33 mL
50 mM 0.07 mL 0.33 mL 0.67 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

参考文献 for AZ Dyrk1B 33

参考文献是支持产品生物活性的出版物。

Kettle et al (2015) Discovery and optimization of a novel series of Dyrk1B kinase inhibitors to explore a MEK resistance hypothesis. J.Med.Chem. 58 2834 PMID: 25738750


If you know of a relevant reference for AZ Dyrk1B 33, please let us know.

按标靶查看相关产品

按产品操作查看相关产品

查看全部 DYRK Inhibitors

关键词: AZ Dyrk1B 33, AZ Dyrk1B 33 supplier, AZDyrk1B33, Dyrk1B, kinase, inhibitors, inhibits, dual, specificity, tyrosine, phosphorylation, regulated, kinases, potent, DYRK, 5632, Tocris Bioscience

篇 AZ Dyrk1B 33 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 AZ Dyrk1B 33 的引用文献。 您是否知道使用了 Tocris AZ Dyrk1B 33 的优秀论文? 请告知我们.

AZ Dyrk1B 33 的评论

目前没有该产品的评论。 Be the first to review AZ Dyrk1B 33 and earn rewards!

Have you used AZ Dyrk1B 33?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Alzheimer's Disease Poster

Alzheimer's Disease Poster

Alzheimer's disease (AD) is a debilitating and progressive neurodegenerative disease and the most common cause of dementia, affecting approximately 30% of individuals aged over 85 years. This poster summarizes the cellular and molecular mechanisms of AD.

Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.